Health Risks and Benefits of Vaccination
Vaccination offers substantial benefits that far outweigh potential risks, with benefits including protection against disease, prevention of death, improved quality of life, and creation of herd immunity against communicable diseases. 1
Benefits of Vaccination
Vaccines provide critical protection at both individual and community levels:
Individual benefits:
Societal benefits:
- Creation and maintenance of herd immunity
- Prevention of disease outbreaks
- Reduction in healthcare-related costs 1
Risks of Vaccination
While vaccines carry some risks, they are generally minimal compared to the benefits:
- Common risks: Minor, local adverse effects (e.g., soreness at injection site, low-grade fever)
- Rare risks: Severe and life-threatening conditions 1
For example, with influenza vaccination:
- Among adults aged 50-64 years with high-risk conditions, effectiveness against hospitalization was 36% compared to 90% in healthy adults 1
- Among patients with diabetes mellitus, vaccination was associated with 56% reduction in complications, 54% reduction in hospitalizations, and 58% reduction in deaths 1
Special Populations and Considerations
Pregnancy
- Inactivated vaccines: No evidence of risk from vaccinating pregnant women with inactivated virus or bacterial vaccines or toxoids 1
- Live vaccines: Pose theoretical risk to the fetus and are generally contraindicated 1
- Recommended vaccines during pregnancy:
Breastfeeding
- Neither killed nor live vaccines affect the safety of breastfeeding for mothers or infants
- Breastfeeding does not adversely affect immunization and is not a contraindication for any vaccine
- Breastfed infants should be vaccinated according to routine recommended schedules 1
Premature Infants
- Premature infants should be vaccinated at the same chronological age using the same doses as term infants
- For hepatitis B vaccination in premature infants with low birthweights (<2,000g):
- If born to HBsAg-positive mothers: Must receive immunoprophylaxis within 12 hours of birth
- If born to HBsAg-negative mothers: First dose should be given at chronological age 1 month or at hospital discharge 1
Immunocompromised Individuals
- HIV-infected persons with minimal symptoms and normal/near-normal CD4+ counts can produce adequate antibody concentrations after vaccination 1
- Persons with advanced HIV disease and low CD4+ counts may not develop protective antibody titers 1
- Yellow fever vaccine should be used with caution in persons with moderate immune suppression (CD4 counts 200-499/mm³) 1
Older Adults
- Adults aged ≥60 years may be at increased risk for serious adverse events after certain vaccinations
- For yellow fever vaccine, the rate of serious adverse events in persons aged ≥60 years was 8.3 events per 100,000 doses compared with 4.7 events per 100,000 doses for all recipients 1
Common Misconceptions and True Contraindications
Many perceived contraindications to vaccines are not actually valid reasons to avoid vaccination. True contraindications include:
- Severe allergic reaction to a vaccine component
- Known immunodeficiency for live vaccines
- Pregnancy for certain live vaccines 2
Balancing Benefits and Risks
When evaluating vaccination, it's important to consider:
- The risk of the disease itself (morbidity and mortality)
- The effectiveness of the vaccine in preventing disease
- The potential adverse effects of the vaccine
- The individual's risk factors and health status
Vaccine hesitancy remains a significant public health challenge, often fueled by misinformation. Recent studies have shown that declining vaccination rates have led to outbreaks of preventable diseases like measles in Europe and North America 3.
Conclusion
The Advisory Committee on Immunization Practices (ACIP) recommendations balance scientific evidence of benefits against potential costs and risks to achieve optimal protection against infectious disease 1. While no vaccine is completely safe or 100% effective, the benefits of vaccination in preventing serious illness, disability, and death from vaccine-preventable diseases substantially outweigh the potential risks of adverse effects in almost all cases 1, 4.